Ad
related to: sandoz pharmaceuticals
Search results
Results From The WOW.Com Content Network
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.
Further pharmaceutical research began in 1917 under Arthur Stoll (1887–1971), who is the founder of Sandoz's pharmaceutical department in 1917. [17] In 1918, Arthur Stoll isolated ergotamine from ergot; the substance was eventually used to treat migraine and headaches and was introduced under the trade name Gynergen in 1921.
Sandoz manufactured LSD for research use, and provided ampules to qualified researchers under the trade-name Delysid in 1947. [17] [18] LSD was brought to the attention of the United States in 1949 by Sandoz Laboratories because they believed LSD might have clinical applications. [19]
The Novartis-owned company said its drug, Hyrimoz, will be priced at a 5% discount off Humira’s current list price of $6,922 per month, but that it was also offering an unbranded version of ...
JOHANNESBURG (Reuters) -Aspen Pharmacare is expanding further into China through a deal to buy the Chinese business of Swiss group Sandoz for up to 92.6 million euros ($100.6 million), the South ...
Valeant has followed the same path, acquiring Medicis Pharmaceutical for $2.6 billion in September 2012 for its cosmetics and body aesthetics portfolio and Bausch & Lomb for $8.7 billion for its ...
Mylan Pharmaceuticals was founded as a drug distributor in 1961 by Milan Puskar and ... putting it in line behind Hikma and Sandoz to launch a generic version in ...
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs , but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing ...